The share capital increase has been duly registered in the
-End-
Contacts
Interim CEO and CFO,
Rune.skeie@bergenbio.com
Forward looking statements
This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
https://news.cision.com/bergenbio-asa/r/bergenbio-asa--share-capital-increase,c3404223
https://mb.cision.com/Main/15728/3404223/1459714.pdf
(c) 2021 Cision. All rights reserved., source